Cancer Biotherapy and Radiopharmaceuticals

Cancer Biother Radiopharm

1084-9785

1557-8852

Therapeutic Area

Nuclear Medicine, Oncology, Pharmacology, Radiology, Research

Biomedical Researchers, Epidemiologists, Nuclear Medicine Physicians, Oncologists, Pathologists, Pharmacologists, Radiation Oncologists, Radiologists, Researchers

Cancer Biotherapy and Radiopharmaceuticals provides peer-reviewed research on cutting-edge therapeutic investigations and advancements in radioimmunotherapy for treating cancer. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies. The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments. Coverage includes: Antibody drug conjugates, Fusion toxins and immunotoxins, Nanoparticle therapy, Vascular therapy, Inhibitors of proliferation signaling pathways.

No associations affiliated with this journal

Mary Ann Liebert, Inc.

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines